Does APREMILAST Cause Peripheral venous disease? 771 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 771 reports of Peripheral venous disease have been filed in association with APREMILAST (Otezla). This represents 0.6% of all adverse event reports for APREMILAST.
771
Reports of Peripheral venous disease with APREMILAST
0.6%
of all APREMILAST reports
748
Deaths
684
Hospitalizations
How Dangerous Is Peripheral venous disease From APREMILAST?
Of the 771 reports, 748 (97.0%) resulted in death, 684 (88.7%) required hospitalization, and 691 (89.6%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 771 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
SECUKINUMAB (1,186)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
Which APREMILAST Alternatives Have Lower Peripheral venous disease Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA